People with late-onset MS, who experience their first symptoms after age 50, tend to have faster disability progression, ...

For columnist Desiree Lama, MS Awareness Month is an opportunity for people living with MS to speak their truth about their ...

A clinical trial in China testing ICP-538, a treatment candidate for MS and other autoimmune diseases, has dosed its first healthy volunteer.

Learning acceptance is a process for guest writer. On a positive note, MS has taught her how to appreciate life more.

People with MS who carry the APOE4 gene variant show greater signs of nerve damage and cognitive decline than those who don't ...

In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...

People with MS have persistently high levels of EBV antibodies, a study found, pointing to a way to distinguish MS from ...

Guest writer Karen Matingou promised her teenage son she would face living with MS with strength, discipline, and a warrior ...

Guest writer Caitlin Epstein was in the middle of world travels when her MS symptoms worsened, leading to a diagnosis.

Guest writer Shayna Goerdt shares the ups and downs of her journey with MS. Among the highs is advocating for the community, ...

Immunic Therapeutics was granted a patent in Europe that protects all dosing regimens of its MS therapy vidofludimus calcium ...

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...